We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$347B
AUM Growth
+$11.3B
Cap. Flow
-$1.57B
Cap. Flow %
-0.45%
Top 10 Hldgs %
12.67%
Holding
4,430
New
161
Increased
2,590
Reduced
1,402
Closed
170

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$714M
2
IBM icon
IBM
IBM
+$395M
3
CSCO icon
Cisco
CSCO
+$303M
4
PG icon
Procter & Gamble
PG
+$290M
5
M icon
Macy's
M
+$237M

Sector Composition

Rank Sector Weight
1 Technology 15.6%
2 Financials 14.73%
3 Healthcare 12.36%
4 Industrials 10.02%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVOK
4026
DELISTED
Evoke Pharma
EVOK
$23K ﹤0.01%
+79
New +$20.5K
PLXP
4027
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$23K ﹤0.01%
+1,762
New +$64.7K
TRNX
4028
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$23K ﹤0.01%
3
-1
-25% -$8.63K
GALT icon
4029
Galectin Therapeutics
GALT
$356M
$22K ﹤0.01%
21,950
+779
+4% +$692
MU icon
4030
CALL
Micron Technology
MU
$1.07T
$22K ﹤0.01%
1,000
VERU icon
4031
Veru
VERU
$46M
$22K ﹤0.01%
2,420
-246
-9% -$2.55K
VGZ icon
4032
Vista Gold
VGZ
$328M
$22K ﹤0.01%
+22,991
New +$21.4K
CTHR
4033
DELISTED
Charles & Colvard Ltd
CTHR
$22K ﹤0.01%
1,974
-124
-6% -$1.31K
VSR
4034
DELISTED
Versar, Inc.
VSR
$22K ﹤0.01%
15,777
+1,814
+13% +$2.44K
AMRS
4035
DELISTED
Amyris Inc.
AMRS
$21K ﹤0.01%
1,878
-110
-6% -$1.35K
GMO
4036
DELISTED
General Moly, Inc.
GMO
$21K ﹤0.01%
84,205
-5,049
-6% -$1.31K
FALC
4037
DELISTED
FalconStor Software Inc
FALC
$21K ﹤0.01%
45,736
-3,215
-7% -$2.23K
MARA icon
4038
Marathon Digital Holdings
MARA
$3.56B
$20K ﹤0.01%
+737
New +$24.1K
APPS icon
4039
Digital Turbine
APPS
$1.53B
$19K ﹤0.01%
27,372
-39,095
-59% -$30.5K
PRKR
4040
DELISTED
Parkervision Inc
PRKR
$19K ﹤0.01%
10,072
-646
-6% -$2.01K
BONT
4041
DELISTED
Bon-Ton Stores Inc/The
BONT
$19K ﹤0.01%
12,914
+1,344
+12% +$2.15K
PERF
4042
DELISTED
Perfumania Holdings, Inc.
PERF
$19K ﹤0.01%
12,562
-776
-6% -$1.43K
ACHV icon
4043
Achieve Life Sciences
ACHV
$744M
$18K ﹤0.01%
16
-1
-6% -$988
VXRT
4044
DELISTED
Vaxart
VXRT
$18K ﹤0.01%
1,330
-105
-7% -$1.6K
BRN icon
4045
Barnwell Industries
BRN
$13.9M
$17K ﹤0.01%
10,483
-652
-6% -$1.08K
IRD
4046
Opus Genetics
IRD
$309M
$17K ﹤0.01%
248
-15
-6% -$1.22K
TEAR
4047
DELISTED
TearLab Corporation
TEAR
$17K ﹤0.01%
3,228
-201
-6% -$1.14K
BLRX
4048
BioLineRX
BLRX
$11.8M
$16K ﹤0.01%
30
-1
-3% -$621
PFIE
4049
DELISTED
Profire Energy, Inc
PFIE
$16K ﹤0.01%
11,893
-1,354
-10% -$1.74K
VTNR
4050
DELISTED
Vertex Energy, Inc
VTNR
$16K ﹤0.01%
12,496
-777
-6% -$868

Similar funds

Bank of New York Mellon's Q4 2016 Portfolio in Review

As of Q4 2016, Bank of New York Mellon held 4,430 positions worth $347B, up 3.3% from $336B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bank of New York Mellon's Q4 2016 filing shows 161 new, 2,590 increased, 1,402 reduced and 170 closed positions. Its largest new stake was Lamb Weston: 2,449,932 shares worth $92.7M. The largest sale was Merck, an estimated $714M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Bank of New York Mellon's largest Q4 2016 buy was Lamb Weston: 2,449,932 shares worth $92.7M.
  • Bank of New York Mellon added most to CME Group in Q4 2016, an estimated $322M increase.
  • Bank of New York Mellon's biggest Q4 2016 reduction was Merck, cutting an estimated $714M.
  • Bank of New York Mellon fully exited LinkedIn Corporation in Q4 2016, selling an estimated $82.8M.
  • Bank of New York Mellon's ten largest holdings make up 13% of its $347B portfolio in Q4 2016.
  • Bank of New York Mellon opened 161 new positions and closed 170 in Q4 2016.
  • Bank of New York Mellon's portfolio value rose 3.3% quarter-over-quarter to $347B.

Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.